Lara Smith-Weber
President en CONSTELLATION PHARMACEUTICALS, INC. .
Cargos activos de Lara Smith-Weber
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CONSTELLATION PHARMACEUTICALS, INC. | President | 15/07/2021 | - |
Corporate Secretary | 15/07/2021 | - | |
Treasurer | 15/07/2021 | - |
Historial de carrera de Lara Smith-Weber
Antiguos cargos conocidos de Lara Smith-Weber.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ONWARD MEDICAL N.V. | Director of Finance/CFO | - | 01/10/2023 |
MorphoSys US, Inc. | Corporate Officer/Principal | - | - |
MORPHOSYS AG | Comptroller/Controller/Auditor | - | - |
Formación de Lara Smith-Weber.
Stanford University | Graduate Degree |
International Institute for Management Development | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 4 |
Alemania | 2 |
Suiza | 2 |
Operativa
Comptroller/Controller/Auditor | 1 |
President | 1 |
Corporate Secretary | 1 |
Sectorial
Consumer Services | 3 |
Health Technology | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
MORPHOSYS AG | Health Technology |
ONWARD MEDICAL N.V. | Commercial Services |
Empresas privadas | 2 |
---|---|
Constellation Pharmaceuticals, Inc.
Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
MorphoSys US, Inc. |
- Bolsa de valores
- Insiders
- Lara Smith-Weber
- Experiencia